Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

NCT06228482 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Nonsmall Cell Lung Cancer

Interventions

DRUG: [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.

Sponsor

University of California, Davis

Collaborators

[object Object]